LOBEF (LOBEF) Stock Price & Analysis
LOBEF (LOBEF) rose 3.17% to USD 0.01 as of July 25, 2026 at 06:04 UTC, according to Nexqual real-time market data.
LOBEF last closed at USD 0.01; the session ranged USD 0.06–0.07 on volume of 12,670 shares. Market capitalization is $2.00M, with a 52-week range of USD 0–0.07 (OQB). Source: Nexqual, July 25, 2026 at 06:04 UTC.
Key Statistics (as of July 25, 2026 at 06:04 UTC)
| Price | USD 0.01 |
|---|---|
| Change | ▲ 3.17% (up) |
| Previous Close | USD 0.01 |
| Open | USD 0.07 |
| Day Range | USD 0.06 – 0.07 |
| 52-Week Range | USD 0 – 0.07 |
| Volume | 12,670 shares |
| Market Cap | $2.00M |
| Exchange | OQB |
Technical Analysis (LOBEF)
Nexqual's technical model rates LOBEF "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 06:04 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 41.5 (neutral) |
| vs SMA50 | Below (USD 0.01) |
| MACD | -0 (negative) |
Analyst Ratings (LOBEF)
Wall Street analysts rate LOBEF "None", per Nexqual as of July 25, 2026 at 06:04 UTC.
| Consensus Rating | None |
|---|
Earnings (LOBEF)
Source: Nexqual, July 25, 2026 at 06:04 UTC.
Financials & Fundamentals (LOBEF)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| Debt / Equity | 17.16 |
| Current Ratio | 1.75 |
| Total Cash | $4.96M |
| Total Debt | $316,486 |
| Free Cash Flow | $-2.34M |
Source: Nexqual, July 25, 2026 at 06:04 UTC.
Financial Health Score (LOBEF)
Nexqual rates LOBEF's overall financial health "Weak" across five dimensions, as of July 25, 2026 at 06:04 UTC.
| Growth | Critical — Revenue -63% YoY (annual), sharp decline |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Strong — $5M cash, no debt |
| Cash Flow | Weak — FCF negative: -$2M, burning cash |
| Efficiency | Mixed — No data |
Ownership (LOBEF)
| Insider Ownership | +63.62% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 308.18M |
| Float | 194.00M |
Source: Nexqual, July 25, 2026 at 06:04 UTC.
Leadership (LOBEF)
LOBEF is led by Frederick Dominick Sancilio M.S. (age 75), Chairman & CEO, per Nexqual as of July 25, 2026 at 06:04 UTC.
| Chairman & CEO | Frederick Dominick Sancilio M.S. (age 75) |
|---|
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| GMVDF | G Medical Innovations Holdings | USD 0 | ▲ 0% |
| AOXG | Aoxing Pharmaceutical Company, | USD 0 | ▲ 0% |
| BBUZ | Bebuzee Inc. | USD 0.02 | ▼ 9.09% |
| KCRD | Kindcard Inc. | USD 0.03 | ▲ 0% |
| SLDC | SOLIDUS COMMUNICATIONS INC. | USD 0 | ▼ 8.33% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 06:04 UTC. This page is informational and not investment advice.